Microdialysis for monitoring inflammation in newborn and infants operated on cardiopulmonary bypass for congenital heart surgery.

• Conditions: congenital heart disease, capillary leak; Q20-Q28; I78.8; Congenital malformations of the circulatory system; Other diseases of capillaries

• Registration Number: DRKS00003546
• Lead Sponsor: Zentrum für Kinder- und Jugendmedizin des Universitätsklinikums FreiburgKlinik III: Angeborene Herzfehler / Pädiatrische Kardiologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2009-10-19
• Study Start: 2012-11-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 23

Inclusion Criteria

Newborns and infants within the first year of life who underwent cardiac surgery with cardiopulmonary bypass.

Exclusion Criteria

Children with infection prior to surgery

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Our study should give an answer to question, if it is possible to monitor the extant of inflammatory response to cardiac surgery entailing cardiopulmonary bypass.

Secondary Outcome Measures

Name	Time	Method
If we get feasible data about the postoperative inflammatory response with the aid of microdialysis we want to use microdialysis as a monitoring tool to optimise cardiopulmonary bypass technique.